INTERMEDIATE EVALUATION OF VIVOPTIM - THE MGEN (FRENCH INSURER) PREVENTION PROGRAM FOR CARDIOVASCULAR RISKS

Author(s)

Blachier M1, Vimont A1, Ballouk S2, Le Lann A2, Femery V2
1PUBLIC HEALTH EXPERTISE, Paris, France, 2MGEN, Paris, France

OBJECTIVES:

VIVOPTIM is an innovative prevention program for cardiovascular (CV) risks designed and financed by the French insurer MGEN Union. It is a personalized program based on digital services, telemedicine devices and direct coaching. A pilot program was launched in 2015 in two French regions (Midi Pyrénées and Bourgogne). A total of 15 different prevention programs were proposed: obesity, atherosclerosis, hypertension, physical activity… based on their CV risk profile. An evaluation of VIVOPTIM after 10 months of follow up was conducted.

METHODS:

The clinical data collected longitudinally and routinely during the program was described and analyzed. Evolution of risk factors between ‘highly active’ participants and ‘weakly active’ participants were compared with univariate and multivariate analyses. The participation was measured by the time spent with a coach or connected to the web platform. VIVOPTIM results were compared with results of other published prevention programs.

RESULTS: CONCLUSIONS:

VIVOPTIM shows similar efficacy results as already published programs. Extrapolation of these results with standard risk scores (SCORE and Framingham equations) shows that this pilot program conducted in two regions could have avoided 29 cardiovascular events.

Conference/Value in Health Info

2017-11, ISPOR Europe 2017, Glasgow, Scotland

Value in Health, Vol. 20, No. 9 (October 2017)

Code

PCV133

Topic

Health Service Delivery & Process of Care

Topic Subcategory

Treatment Patterns and Guidelines

Disease

Cardiovascular Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×